Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Howard

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Communications Biology|March 9, 2021
Programmable half-life and anti-tumour effects of bispecific T-cell engager-albumin fusions with tuned FcRn affinityOle A Mandrup, Sui Ching Ong, Simon Lykkemark, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 3, 2010
siRNA nanoparticle functionalization of nanostructured scaffolds enables controlled multilineage differentiation of stem cellsMorten Ø Andersen, Jens V Nygaard, Jorge S Burns, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 8, 2020
FcRn overexpression in human cancer drives albumin recycling and cell growth; a mechanistic basis for exploitation in targeted albumin-drug designsMaja Thim Larsen, Ole A Mandrup, Karen Kræmmer Schelde, et al.
Proteomics|December 31, 2013
Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factorsDennis Kjølhede Jeppesen, Arkadiusz Nawrocki, Steffen Grann Jensen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 17, 2016
An albumin-mediated cholesterol design-based strategy for tuning siRNA pharmacokinetics and gene silencingKonrad Bienk, Michael Lykke Hvam, Malgorzata Maria Pakula, et al.
ACS Nano|July 4, 2009
Size-Dependent Accumulation of PEGylated Silane-Coated Magnetic Iron Oxide Nanoparticles in Murine TumorsEsben K U Larsen, Thomas Nielsen, Thomas Wittenborn, et al.
Pharmaceutical Research|September 9, 2010
Pulmonary gene silencing in transgenic EGFP mice using aerosolised chitosan/siRNA nanoparticlesEbbe J B Nielsen, Jan M Nielsen, Daniel Becker, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 11, 2006
RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle systemKenneth A Howard, Ulrik L Rahbek, Xiudong Liu, et al.
Pharmaceutical Research|November 2, 2014
Tunable CD44-specific cellular retargeting with hyaluronic acid nanoshellsMorten F Ebbesen, Morten Tj Olesen, Mikkel C Gjelstrup, et al.
Nanoscale|March 8, 2012
Accumulation of magnetic iron oxide nanoparticles coated with variably sized polyethylene glycol in murine tumorsEsben Kjær Unmack Larsen, Thomas Nielsen, Thomas Wittenborn, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Communications Biology|March 9, 2021
Programmable half-life and anti-tumour effects of bispecific T-cell engager-albumin fusions with tuned FcRn affinityOle A Mandrup, Sui Ching Ong, Simon Lykkemark, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 3, 2010
siRNA nanoparticle functionalization of nanostructured scaffolds enables controlled multilineage differentiation of stem cellsMorten Ø Andersen, Jens V Nygaard, Jorge S Burns, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 8, 2020
FcRn overexpression in human cancer drives albumin recycling and cell growth; a mechanistic basis for exploitation in targeted albumin-drug designsMaja Thim Larsen, Ole A Mandrup, Karen Kræmmer Schelde, et al.
Proteomics|December 31, 2013
Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factorsDennis Kjølhede Jeppesen, Arkadiusz Nawrocki, Steffen Grann Jensen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 17, 2016
An albumin-mediated cholesterol design-based strategy for tuning siRNA pharmacokinetics and gene silencingKonrad Bienk, Michael Lykke Hvam, Malgorzata Maria Pakula, et al.
ACS Nano|July 4, 2009
Size-Dependent Accumulation of PEGylated Silane-Coated Magnetic Iron Oxide Nanoparticles in Murine TumorsEsben K U Larsen, Thomas Nielsen, Thomas Wittenborn, et al.
Pharmaceutical Research|September 9, 2010
Pulmonary gene silencing in transgenic EGFP mice using aerosolised chitosan/siRNA nanoparticlesEbbe J B Nielsen, Jan M Nielsen, Daniel Becker, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 11, 2006
RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle systemKenneth A Howard, Ulrik L Rahbek, Xiudong Liu, et al.
Pharmaceutical Research|November 2, 2014
Tunable CD44-specific cellular retargeting with hyaluronic acid nanoshellsMorten F Ebbesen, Morten Tj Olesen, Mikkel C Gjelstrup, et al.
Nanoscale|March 8, 2012
Accumulation of magnetic iron oxide nanoparticles coated with variably sized polyethylene glycol in murine tumorsEsben Kjær Unmack Larsen, Thomas Nielsen, Thomas Wittenborn, et al.
Pageof 9